249 related articles for article (PubMed ID: 31160390)
1. The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive Immunity.
Li XX; Lee JD; Kemper C; Woodruff TM
J Immunol; 2019 Jun; 202(12):3339-3348. PubMed ID: 31160390
[TBL] [Abstract][Full Text] [Related]
2. The complement receptor C5aR2 promotes protein kinase R expression and contributes to NLRP3 inflammasome activation and HMGB1 release from macrophages.
Yu S; Wang D; Huang L; Zhang Y; Luo R; Adah D; Tang Y; Zhao K; Lu B
J Biol Chem; 2019 May; 294(21):8384-8394. PubMed ID: 30971430
[TBL] [Abstract][Full Text] [Related]
3. C5aR2 Activation Broadly Modulates the Signaling and Function of Primary Human Macrophages.
Li XX; Clark RJ; Woodruff TM
J Immunol; 2020 Aug; 205(4):1102-1112. PubMed ID: 32611725
[TBL] [Abstract][Full Text] [Related]
4. The C5a/C5aR2 axis promotes renal inflammation and tissue damage.
Zhang T; Wu KY; Ma N; Wei LL; Garstka M; Zhou W; Li K
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32191644
[TBL] [Abstract][Full Text] [Related]
5. C5aR2 receptor: The genomic twin of the flamboyant C5aR1.
Das A; Gupta PK; Rana S
J Cell Biochem; 2022 Nov; 123(11):1841-1856. PubMed ID: 35977039
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of anaphylatoxin C5a on antigen presenting cells, roles for C5aR1 and C5aR2.
Zaal A; van Ham SM; Ten Brinke A
Immunol Lett; 2019 May; 209():45-52. PubMed ID: 30959077
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
8. Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2.
Das A; Ghosh M; Gupta PK; Rana S
J Cell Biochem; 2023 Feb; 124(2):266-281. PubMed ID: 36565188
[TBL] [Abstract][Full Text] [Related]
9. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma.
Nabizadeh JA; Manthey HD; Panagides N; Steyn FJ; Lee JD; Li XX; Akhir FNM; Chen W; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
FASEB J; 2019 Oct; 33(10):11060-11071. PubMed ID: 31298935
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes.
Haggadone MD; Grailer JJ; Fattahi F; Zetoune FS; Ward PA
Mediators Inflamm; 2016; 2016():1340156. PubMed ID: 27382187
[TBL] [Abstract][Full Text] [Related]
11. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
[TBL] [Abstract][Full Text] [Related]
12. Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration.
Wu MCL; Lee JD; Ruitenberg MJ; Woodruff TM
J Immunol; 2020 Nov; 205(10):2834-2839. PubMed ID: 33028618
[TBL] [Abstract][Full Text] [Related]
13. Integrating complement into the molecular pathogenesis of Hidradenitis Suppurativa.
Grand D; Navrazhina K; Frew JW
Exp Dermatol; 2020 Jan; 29(1):86-92. PubMed ID: 31688984
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients.
Emtenani S; Holtsche MM; Stahlkopf R; Seiler DL; Burn T; Liu H; Parker M; Yilmaz K; Dikmen HO; Lang MH; Sadik CD; Karsten CM; van Beek N; Ludwig RJ; Köhl J; Schmidt E
Front Immunol; 2022; 13():942493. PubMed ID: 36466856
[TBL] [Abstract][Full Text] [Related]
15. Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.
Croker DE; Monk PN; Halai R; Kaeslin G; Schofield Z; Wu MC; Clark RJ; Blaskovich MA; Morikis D; Floudas CA; Cooper MA; Woodruff TM
Immunol Cell Biol; 2016 Sep; 94(8):787-95. PubMed ID: 27108698
[TBL] [Abstract][Full Text] [Related]
16. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists.
Li XX; Clark RJ; Woodruff TM
Int Immunopharmacol; 2021 Nov; 100():108074. PubMed ID: 34454293
[TBL] [Abstract][Full Text] [Related]
17. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells.
Arbore G; West EE; Spolski R; Robertson AAB; Klos A; Rheinheimer C; Dutow P; Woodruff TM; Yu ZX; O'Neill LA; Coll RC; Sher A; Leonard WJ; Köhl J; Monk P; Cooper MA; Arno M; Afzali B; Lachmann HJ; Cope AP; Mayer-Barber KD; Kemper C
Science; 2016 Jun; 352(6292):aad1210. PubMed ID: 27313051
[TBL] [Abstract][Full Text] [Related]
18. The Novel Receptor C5aR2 Is Required for C5a-Mediated Human Mast Cell Adhesion, Migration, and Proinflammatory Mediator Production.
Pundir P; MacDonald CA; Kulka M
J Immunol; 2015 Sep; 195(6):2774-87. PubMed ID: 26283482
[TBL] [Abstract][Full Text] [Related]
19. Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury.
Poppelaars F; van Werkhoven MB; Kotimaa J; Veldhuis ZJ; Ausema A; Broeren SGM; Damman J; Hempel JC; Leuvenink HGD; Daha MR; van Son WJ; van Kooten C; van Os RP; Hillebrands JL; Seelen MA
FASEB J; 2017 Jul; 31(7):3193-3204. PubMed ID: 28396344
[TBL] [Abstract][Full Text] [Related]
20. The Controversial C5a Receptor C5aR2: Its Role in Health and Disease.
Zhang T; Garstka MA; Li K
J Immunol Res; 2017; 2017():8193932. PubMed ID: 28706957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
